Community Interest in Vision Screening Technology
Virtual reality (VR) is a relatively new, emerging field within healthcare. Studies have analyzed public perceptions of virtual reality in healthcare using social media, but few have actually demonstrated and educated these modalities to communities. Because vision care...
Age: 18 years - 66+
Gender: All
Community Interest in Vision Screening Technology
Virtual reality (VR) is a relatively new, emerging field within healthcare. Studies have analyzed public perceptions of virtual reality in healthcare using social media, but few have actually demonstrated and educated these modalities to communities. Because vision care...
Age: 18 years - 66+
Gender: All
REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients
A phase 2 study, aiming to evaluate the efficacy, safety and pharmacokinetics of REC 0/0559
in treatment of Neurotrophic Keratitis in Adult Patient in Europe and United States of
America.
Age: 18 years - 66+
Gender: All
Snapshot Camera for AMD
This study proposes to use a new instrument (AO-OCT/AF: adaptive optics - optical coherence tomography/autofluorescence) combined with a data processing method to image the retinal pigment epithelium (RPE) of the eye in normal subjects and in subjects with age-related m...
Age: 60 - 90 years
Gender: All
Telemedicine in Age-Related Macular Degeneration (AMD)
AMD affects 15 million Americans, with 200,000 new advanced cases diagnosed each year. AMD is the leading cause of blindness in this country, from either the “dry” or “wet” advanced forms. At present, there is no treatment for dry AMD. Besides bl...
Age: 50 - 90 years
Gender: All
A Snapshot Adaptive Optics and Hyperspectral Autofluorescence Fundus Camera for Age-Related Macular Degeneration (AMD)
The purpose of this study is to learn more about age-related macular degeneration (AMD) by using a new investigational technology, AO-(adaptive optics) OCT (optical coherence tomography) with hyperspectral autofluorescence (AF). While currently there is no cure for AMD,...
Age: 18 - 95 years
Gender: All
Macular Vessel Density and Foveal Avascular Zone Changes in Exfoliation Glaucoma vs Primary Open Angle Glaucoma vs Exfoliation Syndrome: An Optical Coherence Tomography Angiography Study
Glaucoma is an eye disease that results in damage to cells in the back of the eye known as the retina and poses a major risk to global public health. Primary open angle glaucoma (POAG) is the most common type of glaucoma in the United States. Exfoliation syndrome (XFS) ...
Age: 40 - 90 years
Gender: All
Sensitivity and Specificity of the NOVA-VEP (FP) Fixed Protocol for Glaucoma Diagnosis
This study is utilizing electrophysiology, called Visual Evoked Potental (VEP) and pattern Electroretinography (ERG) to measure the electrical activity of the visual pathway. VEP measures the electrical activity of the entire vision system. When light enters the eye, it...
Age: 18 - 90 years
Gender: All
A Double-Masked, Placebo-Controlled, Randomized, Phase II Clinical Trial To Assess The Efficacy Of SCH1 In The Treatment Of Acute Infectious Conjunctivitis
Acute infectious conjunctivitis is a leading cause of ocular morbidity, epidemic eye infection, lost productivity, patient discomfort and in some cases permanent visual compromise. The infectious agent is frequently viral in origin and frequently bacterial in origin wit...
Age: 18 - 90 years
Gender: All
Protocol for the Collection of Blood and Surgical Specimens from Patients With and Without Glaucoma
We plan to identify the anatomical, biochemical and genetic differences between normal and glaucomatous eyes using various using tissue samples from the eye and blood.
Age: 18 - 90 years
Gender: All
African Descent and Glaucoma Evaluation Study
According to the National Eye Institute, Glaucoma affects about three million Americans.
Among Blacks in the United States, open- angle glaucoma is the leading cause of irreversible
visual loss. Glaucoma is four times more likely to develop in Blacks than in Whites....
Age: 18 years - 66+
Gender: All
African Descent and Glaucoma Evaluation Study
According to the National Eye Institute, Glaucoma affects about three million Americans.
Among Blacks in the United States, open- angle glaucoma is the leading cause of irreversible
visual loss. Glaucoma is four times more likely to develop in Blacks than in Whites....
Age: 18 years - 66+
Gender: All